XEN1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, Open-Label Extension of a Phase 2b study (X-TOLE) in Adults with Focal Epilepsy

Authors
Category Primary study
JournalNeurology
Year 2023
This article has no abstract
Epistemonikos ID: 2d157837a534c77130ccd25b57082fba2051692a
First added on: Nov 03, 2023